Calendar Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Market Closed - Nasdaq 16:00:00 2024-06-13 EDT 5-day change 1st Jan Change
136.3 USD +1.22% Intraday chart for Neurocrine Biosciences, Inc. +2.40% +3.42%

Chart calendar Neurocrine Biosciences, Inc.

b4575d068002f9b8a.cAdFJZrTBq67BIWtA1aNOQZZj2UONlLur8PIhdj77Gc.RWwdScKbd_qDVt_aWxSgYEgyyD1JbiS64fukyY-oqwkvX3ZyqOdo2_ZgzA~d4051470194da2eda394325781179ec4

Upcoming events on Neurocrine Biosciences, Inc.

2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)
2025-02-10 Q4 2024 Earnings Release (Projected)
2025-04-29 Q1 2025 Earnings Release (Projected)

Past events on Neurocrine Biosciences, Inc.

2024-06-13 10:40 Goldman Sachs Global Healthcare Conference
2024-06-05 14:30 Jefferies Global Healthcare Conference
2024-05-22 13:30 Annual General Meeting
2024-05-14 14:20 BofA Securities Health Care Conference
2024-05-11 08:30 American Association of Clinical Endocrinology Meeting - Abstract No:05
2024-05-10 12:00 American Association of Clinical Endocrinology Meeting
2024-05-10 11:10 American Association of Clinical Endocrinology Meeting - Abstract No:14
2024-05-01 08:00 Q1 2024 Earnings Call
2024-05-01 07:00 Q1 2024 Earnings Release
2024-03-19 14:00 Stifel Virtual CNS Conference
2024-03-18 12:00 UBS Virtual CNS Day
2024-03-13 10:15 Barclays Global Healthcare Conference
2024-03-12 08:40 Leerink Partners Global Biopharma Conference
2024-03-05 11:10 TD Cowen Health Care Conference
2024-02-07 08:00 Q4 2023 Earnings Call
2024-02-07 07:00 Q4 2023 Earnings Release
2024-01-09 12:45 JPMorgan Healthcare Conference
2023-12-05 13:00 Analyst Day
2023-11-14 10:00 Jefferies London Healthcare Conference
2023-11-08 NEI Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
788
776
1.52%
1 046
1 058
-1.18%
1 134
1 139
-0.47%
1 489
1 484
0.31%
1 887
1 885
0.1%

2 219

EBITDA
Million USD
Released
Forecast
Spread
79,7
114
-30.31%
192
178
7.55%
131
232
-43.66%
264
336
-21.3%
269
281
-4.33%

556

EBIT
Million USD
Released
Forecast
Spread
72,3
105
-31.23%
163
162
0.44%
103
209
-51.06%
249
289
-13.9%
251
258
-2.84%

568

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
46,5
87,9
-47.11%
107
129
-17.29%
101
181
-43.99%
214
241
-11.43%
332
296
12.11%

546

Net income
Million USD
Released
Forecast
Spread
37,0
78,4
-52.81%
407
121
236.66%
89,6
148
-39.37%
155
188
-17.63%
250
225
11.11%

431

EPS
USD
Released
Forecast
Spread
0,39
0,82
-52.34%
4,16
1,23
238.86%
0,92
1,51
-39.1%
1,56
1,88
-17.15%
2,47
2,22
11.3%

4,06

Announcement Date04/02/2004/02/2111/02/2206/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
311
304
2.15%
378
343
10.12%
388
377
2.96%
412
409
0.74%
420
409
2.78%
453
448
1.05%
499
479
4.13%
515
518
-0.62%
515
512
0.64%

547


569


590


588


616

EBITDA
Million USD
Released
Forecast
Spread
6,80
43,3
-84.3%
59,0
75,6
-21.96%
91,8
109
-16.04%
107
155
-30.67%
-109
42,8
-355.18%
78,7
126
-37.5%
144
147
-1.74%
155
149
4.23%
106
127
-16.67%

146


159


136







EBIT
Million USD
Released
Forecast
Spread
3,10
39,1
-92.07%
54,7
66,7
-17.94%
87,8
96,8
-9.28%
103
136
-23.91%
-114
14,7
-874.64%
73,6
99,5
-26.06%
141
125
12.9%
150
154
-2.64%
99,3
118
-15.82%

146


163


172


131


166

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
21,4
33,6
-36.38%
-23,3
61,7
-137.75%
97,9
89,2
9.71%
118
135
-12.69%
-103
33,1
-412.49%
122
98,0
24.07%
116
132
-12.2%
198
159
24.47%
34,5
129
-73.3%

140


178


185


142


178

Net income
Million USD
Released
Forecast
Spread
13,9
30,8
-54.88%
-16,9
58,1
-129.08%
68,5
76,2
-10.08%
89,0
118
-24.66%
-76,6
8,27
-1026.71%
95,5
75,4
26.62%
83,1
97,8
-15.04%
148
115
28.34%
43,4
101
-57.11%

114


134


147


109


137

EPS
USD
Released
Forecast
Spread
0,14
0,33
-57.17%
-0,18
0,62
-128.85%
0,69
0,79
-13.19%
0,88
1,15
-23.33%
-0,79
0,04
-2143.98%
0,95
0,77
23.93%
0,82
0,97
-15.1%
1,44
1,12
28.46%
0,42
1,00
-57.99%

1,03


1,25


1,31


1,18


1,40

Announcement Date04/05/2204/08/2201/11/2206/02/2303/05/2301/08/2331/10/2307/02/2401/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Calendar Neurocrine Biosciences, Inc.